| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.098 | 0.8 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.097 | 0.8 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |